Zenflow

Zenflow is a medical device company dedicated to transforming the treatment of urinary obstruction caused by enlarged prostate (BPH). The company’s innovative Spring® technology is designed with the patient experience in mind, utilizing a small spring-like coil that gently props open the urethra, restoring its natural function while preserving anatomy. Though the Zenflow Spring System is currently investigational and not yet commercially available, it holds significant promise for providing a minimally invasive treatment option for men suffering from BPH.

Founded at the Stanford Byers Center for Biodesign, Zenflow’s team is driven by a passion for patient-centered care and is composed of professionals with deep expertise from successful startups and leading global medical device companies. The company’s approach focuses on addressing clinical needs from the patient’s perspective, while challenging traditional industry assumptions to drive innovation. By maintaining a strong commitment to improving the lives of BPH patients, Zenflow aims to offer a superior, effective solution for managing this common condition.

Zenflow's value proposition lies in its innovative, minimally invasive Spring® technology, which promises to deliver better outcomes for patients with BPH, offering an alternative to current treatments that require tissue removal or invasive procedures. Zenflow’s ongoing research and dedication to patient-centric solutions place the company at the forefront of next-generation treatments for BPH.